Antibody Discovery Services and Platforms Market Revenue to Cross US$ 6.2 billion by 2035

Published: January 2024


According to a recently published report by Roots Analysis, the increasing adoption of antibody-based therapeutics and the success of such therapies in treating various target disease indications is driving antibody discovery services and platforms market growth.

Antibody Discovery Services and Platforms Industry Overview

The global antibody discovery services and platforms market is anticipated to grow at a CAGR of 11.0% from 2023-2035, reaching USD 6.2 billion by 2035.

Antibodies, also known as immunoglobulins, are Y-shaped glycoproteins that are produced by the immune system in response to foreign molecules that enter the body. The antibody works by recognizing a specific region on an antigen, called an epitope, binds to it and mediates an immune response against it. Upon binding to the epitope, it facilitates phagocytosis of the foreign substances in a process called opsonization. As the antibodies can be produced to target specific proteins, they are considered as highly important biomolecules that have the potential to be used in the treatment of various diseases. Further, the antibodies also work in activating the complement system to destroy the bacterial cell by lysis.  With the rising demand for antibody therapeutics in the recent past, the domain of antibody discovery has seen a surge in the outsourcing activities. Companies are turning to CMOs and CDMOs to accelerate their workflow. These organizations are trying newer technologies to provide unique and specialized services in this field.

To order this 550+ page report, which features 130+ figures and 210+ tables, please visit https://www.rootsanalysis.com/reports/antibody-discovery-services-and-platforms-market/213.html

Market Drivers

Various factors contribute to the market growth of antibody discovery services and platforms market. These include the increased investment in antibody discovery services and platforms market that is driving the research into diverse antibody candidates using advanced techniques, such as phage display and single-cell sequencing. This surge in R&D spending accelerates targeted therapy development, boosting the antibody discovery market. Pharmaceutical companies are outsourcing operations to streamline discovery, cut costs, and fasten drug approvals by leveraging specialized knowledge and technologies. Further, as antibody engineering progresses, regulatory agencies have started to acknowledge their potential as effective treatments across a wide spectrum of therapeutic areas.

Market Restraints

One of the primary restraints associated with this industry is regulatory compliance challenges. In most cases, stringent safety and efficacy requirements lead to extended research timelines and higher research costs. Navigating these regulations demands specialized expertise, limiting smaller research team involvement in such development efforts. Further, high costs and time-intensive procedures strain research budgets, limit accessibility, and cause delays in breakthroughs. In addition, patent disputes have been observed in this domain due to overlapping claims on technologies, methods, or antibodies, requiring legal intervention, negotiations, or licensing agreements.

Growth Factors

Despite the challenges, several growth factors continue to drive the antibody discovery services and platforms market forward. One notable factor is the rapid market expansion of antibody therapies, highlighted by Humira's success, generating over USD 21.2 billion in sales in 2022. These molecules are increasingly being adopted for therapeutic, diagnostic, and diverse applications due to a robust development pipeline and high clinical success rates. Start-ups are leveraging this opportunity to develop novel candidates against various diseases, broadening application diversity. In addition, the use of AI and ML technologies have been observed to streamline screening and swiftly identify potential antibody candidates and to predict specific interactions, thereby reducing resource-intensive efforts.

Antibody Discovery Services and Platforms Market Segments

Based on the type of service offered, the antibody discovery services market is segmented into antigen designing, hit generation, lead selection, lead optimization, lead characterization

  • The hit generation segment in antibody discovery services market captures the largest revenue share of 42% in 2023.
  • The lead selection segment is anticipated to show the highest market growth potential during the forecast period of over 12.1% annually.

Based on the type of antibody discovery method, the antibody discovery services market is segmented into hybridoma, phage display, single cell based, transgenic animal based, yeast display and others

  • The hybridoma segment led the antibody discovery services market, capturing the largest revenue share of close to 33% in 2023.
  • The single cell based segment is anticipated to show the highest market growth potential during the forecast period of over 14.7% annually.

Based on the nature of antibody discovered, the antibody discovery services market is segmented into chimeric, human, humanized and murine

  • The human antibody segment led the antibody discovery services market, capturing the largest revenue share of 43% in 2023.
  • In fact, the human antibody segment is anticipated to show the highest growth potential by growing at a CAGR of over 12.3% during the forecast period.

Based on the therapeutic area, the antibody discovery services market is segmented into cardiovascular disorders, immunological disorders, infectious disorders, neurological disorders, oncological disorders and others

  • The oncological disorder segment led the antibody discovery services market, capturing the largest revenue share of 49% in 2023.

  • The cardiovascular disorder segment is anticipated to show the highest growth potential by growing at a CAGR of over 12.2% during the forecast period.

Based on the type of antibody discovered, the antibody discovery platforms market is segmented into monoclonal antibodies, bispecific antibodies and other antibodies

  • The monoclonal antibody segment led the antibody discovery platforms market, capturing the largest revenue share of 55% in 2023.
  • The other antibodies segment is anticipated to show the highest growth potential by growing at a CAGR of over 13.4 % during the forecast period.

Based on the regional insights, the antibody discovery services market is segmented into North America, Europe, Asia, Latin America, Middle East and North Africa and Rest of the World

  • North America dominated the antibody discovery services market and accounted for the largest revenue share of over 30% in 2023.
  • In Asia, and the Middle East and North Africa region, the antibody discovery services market is anticipated to demonstrate lucrative growth during the forecast period.

Key Companies Profiled

The antibody discovery services and platforms market report also includes detailed profiles of key players (listed below) that offer antibody discovery services and platforms:

  • Ablexis
  • Antibody Solutions
  • ChemPartner
  • Creative Biolabs
  • GenScript
  • Genmab
  • Harbour BioMed
  • ImmunoPrecise
  • Mabsilico
  • Myrio Therapeutics
  • Nona Biosciences
  • Rockland Immunochemicals
  • Synbio technologies
  • WuXi Biologics

You Can Download Free Sample PDF Copy of This Report At: 
https://www.rootsanalysis.com/reports/213/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com

MEDIA CITATIONS

  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry